Does post-operative radiotherapy (P-RXT) after radical prostatectomy (Px) improve progression-free survival (PFS) in pT3NO prostate cancer (PC)? (EORTC 22911)

被引：0
|
作者：
Bolla, M
Van Poppel, H
Van Cangh, P
Vekemans, K
Rigatti, P
De Reijke, T
Verbaeys, A
Bosset, JF
Collette, L
机构：
[1] CHR Grenoble, Grenoble, France
[2] UZ Gasthuisberg, Louvain, Belgium
[3] Clin Univ St Luc, B-1200 Brussels, Belgium
[4] Virga Jesse Hosp, Hasselt, Belgium
[5] Ist Sci HS Raffaele, Milan, Italy
[6] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[7] State Univ Ghent, B-9000 Ghent, Belgium
[8] CHR Besancon, Besancon, France
[9] EORTC, Brussels, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4504
引用
收藏
页码：383S / 383S
页数：1
相关论文
共 8 条
  • [1] Post-operative radiotherapy (P-RXT) after radical prostatectorny (Px) improves progression-free survival (PFS) in pT3NO prostate cancer (PC) (EORTC 22911)
    Bolla, M
    Van Poppel, H
    Van Cangh, P
    Vekemans, K
    Rigatti, P
    Haustermans, K
    Bulens, P
    Villa, E
    Collette, L
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S186 - S186
  • [2] Post-operative radiotherapy (P-RXT) after radical prostatectomy (Px) improves progression-free survival (PFS) in pT3N0 prostate cancer (PC)(EORTC 22911)
    Bolla, M
    Van Poppel, H
    Van Cangh, P
    Vekemans, K
    Da Pozzo, L
    Haustermans, K
    Scalliet, P
    Bulens, P
    van Tienhoven, G
    Verbaeys, A
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S126 - S126
  • [3] LONG TERM RESULTS OF IMMEDIATE POSTOPERATIVE RADIOTHERAPY AFTER RADICAL PROSTATECTOMY IN PT3NO PROSTATE CANCER (EORTC 22911).
    Bolla, M.
    Van Poppel, H.
    Tombal, B.
    Vekemans, K.
    Da Pozzo, L. F.
    de Reijke, T.
    Verbaeys, A.
    Bosset, J. F.
    Van Velthoven, R. F.
    Colombel, M.
    van de Beek, C.
    Verhaegen, P.
    van den Bergh, A. C.
    Sternberg, C.
    Gasser, T.
    van Tienhoven, G.
    Scalliet, P.
    Haustermans, T.
    Liberatoscioli, C.
    Collette, L.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S113 - S113
  • [4] Is immediate post-operative radiation of pT3NO prostate cancer a safe treatment?: Results of EORTC-trial 22911
    Van Poppel, H
    Bolla, M
    Van Cangh, P
    Vekemans, K
    Rigatti, P
    De Reijke, T
    Verbaeys, A
    Van Velthoven, R
    Maréchal, JM
    Haustermans, K
    Scalliet, P
    Collette, L
    Pierart, M
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04): : 492 - 492
  • [5] 10-year Results of Adjuvant Radiotherapy after Radical Prostatectomy in pT3N0 Prostate Cancer (EORTC 22911)
    Bolla, M.
    Van Poppel, H.
    Tombal, B.
    Vekemans, K.
    Da Pozzos, L.
    De Reijke, T. M.
    Verbaeys, A.
    Bosset, J. F.
    Van Velthoven, R.
    Collette, L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S29 - S29
  • [6] EORTC trial 22911: Immediate post-prostatectomy irradiation improvves biochemical and clinical progression-free survival in patients with pathologically high risk prostate cancer
    Bolla, M.
    Van Poppel, H.
    Collette, L.
    Van Cangh, P.
    Vekemans, K.
    Da Pozzo, L.
    de Reijke, T. M.
    Verbaeys, A.
    Bosset, J. F.
    Van Velhoven, R. F. P.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 230 - 230
  • [7] Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate Cancer
    Hegde, John V.
    Veruttipong, Darlene
    Said, Jonathan W.
    Reiter, Robert E.
    Steinberg, Michael L.
    King, Christopher R.
    Kishan, Amar U.
    [J]. UROLOGY, 2017, 107 : 171 - 177
  • [8] Does higher number of lymph nodes (LNs) excised during radical prostatectomy (RP) improve biochemical relapse-free survival (bRFS) in patients with pT2-3a/pN0 prostate cancer?
    Seyedin, Steven Neema
    Mitchell, Darrion L.
    Russo, James Kyle
    Mott, Sarah L.
    Parkhurst, Jessica
    Smith, Mark C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
1